A First-in-Human Study of BB-TL1A-VIAL-HLE in Healthy Adults and People With Ulcerative Colitis

Clinical trial NCT07029971 · TERMINATED

Trial details

NCT number: NCT07029971
Sponsor: Vial Australia Pty Ltd
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Ulcerative Colitis (UC)

Start date: 2025-06-23
Primary completion: 2025-12-23
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.